Navigation Links
Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
Date:5/5/2009

JERUSALEM, May 5 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTC: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced that Phase 2b clinical trials will commence this week on 30 Type 2 Diabetic volunteers. The study is intended to evaluate the safety, tolerability and efficacy of its oral insulin capsule ORMD-0801. OnQ Consulting, a clinical research organization (CRO) located in Johannesburg, South Africa, will oversee the clinical trials. This trial is an important milestone for Oramed as it will test its first indication for ORMD-0801 on a large group of volunteers for the duration of six weeks.

This six week randomized, double blind placebo controlled study will be performed in three locations in Cape Town. The principle investigators of the study will be renowned South African Endocrinologists.

"We are pleased to begin this study of ORMD-0801 on Type 2 diabetes patients following our successful 2A clinical trials in August 2008. This trial is an important milestone for Oramed as this is the first trial for ORMD-0801 on a larger group of volunteers for a longer duration." said Oramed's CEO, Mr. Nadav Kidron.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com


'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
2. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
3. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
4. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
5. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
6. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
7. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
8. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
9. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
10. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
11. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro ... Alliance (HITRUST) under its Common Security Framework (CSF). ... Security and Privacy Manager, "We appreciate this rigorous, ... of commitment that this certification signifies. Our business ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal ...
(Date:8/21/2014)... 2014 BreedIT Corp., (OTCQB: ... exclusive worldwide license holder and distributor of highly ... researchers, today is pleased to announce the formation ... Ltd, a leading Israeli medical Cannabis breeder. ... new breeds of medical Cannabis to meet the ...
(Date:8/21/2014)... 21, 2014 InfinityQS International, Inc., the ... Intelligence , today announces Infusion Chicago, its 9 ... be held Oct. 9-10, 2014, at the Chicago ... showcase the necessity for implementing a quality system ... Intelligence to gain insight into production processes. Complimentary ...
Breaking Medicine Technology:ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2
... FORT WASHINGTON, Pa., March 29, 2011 McNeil Consumer ... lot of TYLENOL® 8 Hour Extended Release Caplets 150 ... taking this action as part of our ongoing surveillance ... complaints of a musty or moldy odor. The uncharacteristic ...
... Southern Research Institute, a not-for-profit organization that conducts ... drug discovery and drug development today announced that its ... AACR 102nd Annual Meeting 2011 , April 2-6, ... to meet with scientists at Booth #543. ...
Cached Medicine Technology:McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Products 2Southern Research Scientists to Present New Data at the American Association for Cancer Research 102nd Annual Meeting in Orlando 2Southern Research Scientists to Present New Data at the American Association for Cancer Research 102nd Annual Meeting in Orlando 3
(Date:8/22/2014)... The improved access to antiretroviral drugs ... developing world, has led to the decline in the ... due to AIDS globally. However, despite the fact that ... patients becoming affected by the virus is on the ... all related organisations and stakeholders, by 2015, significant investments ...
(Date:8/22/2014)... NJ. August 22, 2014. A new study ... persons with multiple sclerosis (MS) may be able ... The study was epublished ahead of print on ... Helen Genova, Hali Griswold, Nancy D. Chiaravalloti & ... persons with multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness is ...
(Date:8/22/2014)... CLEVELAND Renal artery stenting to open blockages ... have historically been excluded from modern clinical trials, ... e-published in Catheterization and Cardiovascular Interventions ... Interventions (SCAI). , University Hospitals Case Medical Center,s ... and Professor of Medicine, Case Western Reserve University ...
(Date:8/22/2014)... 22, 2014 Home Care Assistance ... care for seniors, is proud to announce the next ... upcoming webinar will feature Dr. Suzanne Steinbaum, attending cardiologist ... Hospital in New York City, National Spokesperson for the ... webinar will cover the issues surrounding women and heart ...
(Date:8/22/2014)... Many children get anxious or afraid when they have ... of ways that parents can make these shots easier ... step is to explain to children in an age-appropriate ... Rita John, director of the pediatric primary care nurse ... New York City. "Children need to know that ...
Breaking Medicine News(10 mins):Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2
... Avon Global Ambassador,Reese Witherspoon, will travel to Sao ... first-ever global fundraising product, the Women,s,Empowerment Bracelet, which ... Reese will be joined by female luminaries, ... Falu, UNIFEM Regional Director,for the Southern Cone, and ...
... not,women and men have different oral health needs. In ... their life, including,puberty, pregnancy and menopause., The Pennsylvania ... oral health needs will ensure that everyone,regardless of gender ... care they,need to maintain healthy teeth and gums., ...
... reactor facility at Petten in the Netherlands threatens the ... obtain radioactive isotopes, which are critical for performing many ... worldwide. The shutdown at the High Flux Reactor in ... the National Research Universal reactor in Chalk River, Canada ...
... Aug. 27 The National Labor,Relations Board issued ... from the Easton facility had filed a series ... threatening,retaliating against workers, and attempting to bribe workers ... real improvements. They,re,trying to buy us off by ...
... 27 Stand Up For A Cure,s 2008,Concert Series ... a,performance by Grammy(R)-winning Dave Matthews Band at Madison Square,Garden. ... be hosted,by Julia Roberts and will be preceded by ... New York-based non-profit, Stand Up For A Cure created ...
... of Charity Health System Continues to Jeopardize Patient ... Thousands of,healthcare workers will hold a one-day strike ... the Daughters of Charity Health System.,Caregivers were forced ... fairly over proposals aimed to help ensure quality ...
Cached Medicine News:Health News:Reese Witherspoon Visits Brazil to Spread Message of Female Empowerment as Avon's Global Ambassador 2Health News:What You Need to Know About Women's Oral Health 2Health News:SNM expresses serious concerns as isotope shortage looms 2Health News:SNM expresses serious concerns as isotope shortage looms 3Health News:Carlyle-ManorCare Facing New Federal Charges for Breaking the Law: Interrogating, Threatening, Retaliating Against Nursing Home Workers for Trying to Form a Union 2Health News:Julia Roberts Joins Dave Matthews Band at Madison Square Garden in 'Stand Up For A Cure' 2008 Concert Series 2Health News:Thousands of California Healthcare Workers Strike to Protect Their Patients 2
Honing compound for knife sharpening, 6 grams net...
Conversion kit that has 1 - 15 micron feed screw with 1 micron increments for fine cutting (factory fitted)...
Knife sharpening kit...
... is necessary to cool a specimen below room ... to most microtomes and will permit specimen cooling ... conditions. The equipment consists of a cooling stage ... best suited for operation with a base sledge ...
Medicine Products: